Skip Navigation

European Heart Journal 1989 10(Supplement F):36-43; doi:10.1093/eurheartj/10.suppl_F.36
Copyright © 1989 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Förstermann, U.
Right arrow Articles by Frölich, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Förstermann, U.
Right arrow Articles by Frölich, J. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1989 The European Society of Cardiology

Endothelium-derived relaxing factor (EDRF): a defence mechanism against platelet aggregation and vasospasm in human coronary arteries

U. Förstermann, A. Mügge*, U. Alheid, S. M. Bode and J. C. Frölich

Department of Clinical Pharmacology, Hannover Medical School Hannover, F.R.G.
* Department of Cardiology, Hannover Medical School Hannover, F.R.G.

Requests for reprints to: Dr Ulrich Förstermann, Abbott Laboratories, Department 47S, Building AP9A, Abbott Park, Illinois 60064, U.S.A.

The goal of this investigation was to examine the interactions that can occur between platelet and endothelial cells, especially in human coronary arteries. In a first series of experiments, the effect of human endothelial cells (cultured on microcarrier beads) was tested on the aggregation of washed human platelets. Endothelial cells completely inhibited platelet aggregation. The prostacyclin-mediated anti-aggregatory component could be blocked with indomethacin. The remaining anti-aggregatory effect of endothelial cells could be prevented with the EDRF inhibitors, gossypol, haemoglobin and methylene blue. This indicates that the endothelial autacoids, EDRF and prostacyclin, are both inhibitors of platelet aggregation. In a second approach we investigated the effect of aggregating platelets on the tone of human coronary arteries obtained during heart transplantation. Aggregating platelets produced strictly endothelium-dependent relaxations of coronary arterial strips. These relaxations were mainly mediated by EDRF, because inhibition of vascular prostacyclin synthesis with aspirin did not inhibit the relaxations significantly, but the relaxations were abolished by the aforementioned EDRF inhibitors. Platelet-derived adenosine 5'-diphosphate (ADP) is mainly responsible for the stimulation of EDRF production in coronary endothelial cells. ADP was an endothelium-dependent vasodilator, and apyrase (ADP-ase) completely prevented platelet-induced vasodilation. The other platelet products, serotonin and thromboxane A2, were weak and potent constrictors of coronary arteries, respectively. These data suggest that the ADP released by aggregating platelets stimulates the coronary endothelium to produce EDRF. EDRF overrides the constrictor effects of serotonin and thromboxane A2 and exerts an inhibitory effect against further platelet aggregation or adhesion.

Key Words: Human platelets • human coronary arteries • endothelium-derived relaxing factor • aspirin • gossypol • methylene blue • haemoglobin


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.